Lori Williamson, MS, CGC
-----Original Message-----
From: Shuger, Jill (HRSA) [mailto:[log in to unmask]]
Sent: Monday, August 06, 2007 1:57 PM
To: Amy Schwartz; Anne Comeau; Camille Miller; Cynthia Cameron; David
Ledbetter; Gloria Weissman; Hans Anderssen; Janice Bach; John Johnson;
John Moeschler; Mulvihill, John J. (HSC); Joyce Hooker; Judith
Benkendorf; Katharine Harris; Kenneth Pass; Kerry Silvey; Kyler, Penny
(HRSA); Williamson, Lori L. (HSC); Louis Bartoshesky; Mann, Marie
(HRSA); Marzia Pasquali; Michael Watson; Piero Rinaldo; Puryear, Michele
(HRSA); Rani Singh; Roger Eaton; Shuger, Jill (HRSA); Susan Berry; Susan
Waisbren; Sylvia Au
Subject: FW: ACTION NEEDED - SUBMITTING COMMENTS ON NCRR's CTSAs - FED
REGISTER NOTICE
From: APS - SPR Central Office [mailto:[log in to unmask]]
Sent: Mon 8/6/2007 11:00 AM
To: [log in to unmask]
Subject: ACTION NEEDED - SUBMITTING COMMENTS ON THE NCRR - FED REGISTER
NOTICE
**HIGH PRIORITY**
August 5, 2007
TO: APS and SPR members
FROM: Public Policy Council
RE: ACTION NEEDED: SUBMITTING COMMENTS ON THE NATIONAL CENTER
FOR RESEARCH RESOURCES (NCRR) NEW STRATEGIC PLAN
The National Center for Research Resources (NCRR) is seeking comments
and input as it develops a new Strategic Plan covering 2009 - 2013. The
NCRR provides clinical and translational researchers with the training
and tools they need to understand, detect, treat, and prevent a wide
range of diseases.
Responses may be made electronically at:
http://www.ncrr.nih.gov/strategicplan
<http://www.ncrr.nih.gov/strategicplan>. As the Federal Register Notice
states, responses will help guide the discussion at the NCRR's December
2007 Strategic Planning Forum.
It is important that given the opportunity that is presented by the NCRR
to comment on its strategic plan that the pediatric research community
provides comments - in fact the more pediatric voices the better! The
process is simple and hopefully that will encourage participation by
many.
A copy of the text of the Federal Register Notice is included in this
email.
ADDITIONAL BACKGROUND: The NCRR includes the Clinical Translational
Science Award (CTSA). During the reauthorization of the NIH legislation
in 2006, a provision was added through the advocacy efforts of Boston
Children's Hospital and supported by the National Association of
Children's Hospitals (NACH) to require the NIH Director to establish a
mechanism within the CTSA program "to preserve independent funding and
infrastructure for pediatric clinical research by allowing the
appointment of a secondary principal investigator under a single CTSA
with direct authority over a separate budget and infrastructure for
pediatric research, or otherwise securing institutional independence of
pediatric clinical research centers with respect to finances,
infrastructure, resources, and research agenda." The Director is also to
provide an evaluation and comparison of outcomes and effectiveness in
these programs as part of a biennial repor! t to Congress.
Below is the text of the Federal Register notice * the strategic plan is
available by clicking onto the link and it will take you directly there
as well as to submit your comments electronically.
Federal Register
Vol. 72, No. 129
Friday, July 6, 2007
http://www.access.gpo.gov/su_docs/fedreg/a070706c.html
<http://www.access.gpo.gov/su_docs/fedreg/a070706c.html>
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health
National Center for Research Resources 2009 Strategic Plan
AGENCY: National Center for Research Resources, NIH, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In order to prepare for the future, The Nati! onal Center for
Research Resources (NCRR), National Institutes of Health (NIH), is
developing a new strategic plan. The purpose of the plan is to ensure
that NCRR remains responsive to the emerging needs of biomedical
researchers and provides them with the infrastructure, tools, and
training they need to understand, detect, treat, and prevent a wide
range of diseases. The NCRR requests input from biomedical scientists to
define future needs for shared research resources and technologies that
facilitate NIH-supported biomedical research. The NCRR's existing
2004-2008 strategic plan may be accessed over the World Wide Web:
http://www.ncrr.nih.gov/about_us/StrategicPlan2004-08.pdf
<http://www.ncrr.nih.gov/about_us/StrategicPlan2004-08.pdf> .
DATES: Submit responses to the Office of Science Policy and Public
Liaison, NCRR (see below) on or before August 24, 2007.
FOR FURTHER INFORMATION CONTACT: The Office of Science Policy and Public
Liaison, NCRR/NIH/DHHS, 6701 Democracy Boulevard, MSC 4874, Suite 994,
Bethesda, MD 20892-4874, telephone 301-435-0866, FAX 301-480-3654,
e-mail [log in to unmask] <mailto:[log in to unmask]> , Internet
http://www.ncrr.nih.gov <http://www.ncrr.nih.gov/>
SUPPLEMENTARY INFORMATION: The National Center for Research Resources
(NCRR) provides clinical and translational researchers with the training
and tools they need to understand, detect, treat, and prevent a wide
range of diseases. This support enables discoveries that begin at a
molecular and cellular level, move to animal-based studies, and then are
translated to patient-oriented clinical research, resulting in cures and
treatments for both common and rare diseases. NCRR connects researchers
with one another, as well as with patients and communities across the
Nation, to harness the power of shared resources and research.
Transcending geographic boundaries and research disciplines, NCRR
supports unique and essential research and resources that help to
transform basic discoveries into improved human health. Together, the
programs accelerate and enhance research along the entire continuum of
biomedical science to:
Fund clinical and translational science awards at academic health
centers to speed basic discoveries into improved medical care. Working
as a national Consortium, these institutions will develop novel
approaches, enhance informatics, and improve training and mentoring that
will be disseminated across the Consortium and beyond.
Provide access to state-of-the-art technologies and instruments
that enable both basic biomedical research and clinical investigations
of a multitude of health issues, from cancer to infectious diseases.
Develop and provide access to critical animal models, which offer
essential clues to a broad range of human disorders such as Parkinson's
disease, multiple sclerosis, and AIDS.
Train veterinarians in translational research in order to respond
to deadly human diseases, such SARS, influenza, and hepatitis.
Enhance development programs for underserved states and
institutions, focusing on health disparities that negatively impact
racial and ethnic minority populations.
Provide funding to expand, remodel, and renovate or alter existing
research facilities or construct new research facilities.
Fund career development programs that attract talented medical
students, physicians, and dentists to the challenge of clinical research
careers.
Stimulate basic research to develop versatile new technologies and
methods that help researchers to study virtually every human disease.
Increase the public's understanding of medical research and delivers
information about healthy living and career opportunities in science to
children and the general public.
To ensure the continued relevance of its Strategic Plan, the NCRR
seeks input to the following questions in terms of the issues described
above:
What are the most significant trends, developments, and/or needs in
biomedical research that are likely to materialize over the next five
years, and what can NCRR do to be prepared to respond to them?
From the standpoint of achieving the broadest impact among
investigators, what new or expanded research resources and/or animal
models should be developed over the next five to eight years?
The recently introduced CTSA (Clinical Translational Science Award)
Program seeks to transform the local, regional and national environment
for clinical and translational science, thereby increasing the
efficiency and speed of clinical and translational research.
What considerations will be most crucial to the long-term success of
this initiative?
Despite significant progress, research institutions serving
predominantly minority and underserved populations face stiff
challenges. What can NCRR do to most effectively support the long-term
advancement of these institutions?
NCRR has, and will continue to, work closely with many federal and
private sector institutions, agencies, and organizations. Looking
forward, what organizations should NCRR seek out for future partnerships
to most effectively support, expand, and advance its programs and
services?
Is there anything else you would like to add that would be helpful
to NCRR?
For your convenience, we have provided a user-friendly response form
at the NCRR's Strategic Planning Web site:
http://www.ncrr.nih.gov/strategicplan
<http://www.ncrr.nih.gov/strategicplan>.
If you do not have access, please send your responses to the above
address.
Dated: June 21, 2007.
Barbara Alving, Director, NCRR, National Institutes of Health.
[FR Doc. E7-13131 Filed 7-5-07; 8:45 am] BILLING CODE 4140-01-P
|
